During the April 2 Johns Hopkins Medicine Town Meeting, Daniel Ford, vice dean for clinical investigation, shared that even though Johns Hopkins has just as many clinical trials as any other medical institution in the country, only 3 to 4 percent of patients currently being treated at Johns Hopkins are enrolled in a clinical trial. Of the measures Ford mentioned, which do you think will best help enroll more patients in clinical trials? Share your thoughts in today’s poll.
Loading ...
{ 7 comments… read them below or add one }
Comments
Share tangible evidence of how the trails have benefited others, ie.,short videos by consenting benefactors, via in room television broadcasts. People like to know how they can help others.
Inform patients of the treatments they are already receiving that were first tested by volunteers just like them.
I would be happy to join a clinical trial and I am sure there may be some I would fit into, however the process finding one is not user friendly. You have to go down a long list of trials to see if any apply to you and some of the descriptions of the trials may not be written in an easy to understand fashion for people who are not clinical. and familiar with some of the terms. It would be a lot easier if I were at my doctor's office (doctor is also in research) and they told me one of the trials would apply to me and see if I would be interested.
Utilize the language already present in the inpatient agreement and ER consent for treatment forms. These clauses are routinely incomplete. Add the same language to the outpatient agreement and/or present all registering outpatients with IRB Form 3. Indicate on the EPIC snapshot page that the patient has completed any of these forms and their response to being approached for future research.
With the patient's permission, send something through MyChart if he/she is eligible for a Clinical Trial.
Increase, improve, and innovate community outreach, education, and engagement to generate a positive and constructive relationship with local and regional individuals to form more robust partnerships.
Modify the consent for treatment to allow for patients to be screened and contacted if they are eligible for research studies.